The framework has shifted from distribution to markdown since the last review. Price is trending lower. Sellers are in control and the prior trend has reversed. Price has moved down 4.3% since our last review. Ethical screening: PASS with passing ethical screen. The risk-adjusted return profile shows negative risk-adjusted returns. Our composite framework grades it C, carrying a low risk profile. Technically it is momentum reading neutral. Over the past year the shares are up 13%. Our forward projection puts the odds of a 10% gain over the next month near 23%. The street (7 analysts) rates it hold, with a mean price target of $18.
Titan America SA
TTAM · the NYSE · USD · Market cap $2.6B · 2,554 employees
Titan America SA, through its subsidiaries, manufactures and supplies heavy building materials and services in the United States.
PASS · Titan Ethical · score 70.0At the last full screen
2026-09-15
Screened 2026-09-15 · the tape above runs as of 13:00 UTC · two dates, stated on purpose · verdict and workings shown in full · never trimmed
This name holds its markdown label.
Titan America SA holds its Markdown at $14.06. Consolidating, no directional conviction, held for 263 days.
| Phase | Markdown · caution |
| Quantitative state | Consolidating, no directional conviction, held for 263 days |
| Price at the screen | $14.06 |
| Valuation | 14.65 trailing · 11.13 forward price to earnings |
| Values screen | PASS · score 70.0 |
Five Screens, Shown in Full
Full pass across all five screens. This security clears the Titan Ethical Standard: its business and its balance sheet both stay inside the lines.
| Test | Figure | Limit | What it means | Status |
|---|---|---|---|---|
| Business activity | Permissible | Core business clean | Its core business isn't built on prohibited lines: no gambling, alcohol, tobacco, weapons, or interest-based lending. | Pass |
| Debt load | 24.42% | Below 33% | Interest-bearing debt is just 24.4% of its assets, well under the one-third ceiling: it does not run on borrowed money. | Pass |
| Interest-bearing cash | 0.00% | Below 33% | Cash held in interest-bearing accounts and securities is 0.0% of assets, under the one-third limit. | Pass |
| Receivables | 14.05% | Below 49% | Money owed to the company is 14.0% of assets, under the 49% limit. | Pass |
| Revenue purity | 0.35% | Below 5% | Only 0.3% of revenue comes from non-compliant sources, under the 5% line. | Pass |
Five checks adapted from AAOIFI screening standards: business activity plus four balance-sheet ratios. All five must pass for ethical clearance. Every figure is arithmetic on public accounts, not judgement.
What the Numbers Say It Is WorthThe Fair Value Range
Fair value range in USD, drawn from the 2026-09-15 screen. The gold marker is the market price at the same screen. A 3.7% margin of safety to the base estimate.
Third-party analyst targets: 7 covering, consensus Hold. The average target sits +32% from the screen price.
Reading the gap · Both our model and the analysts see meaningful upside from here.
Price History & ProjectionsWhere it has been, where the models see it going. History from market close data; projection points are our fair-value estimates and third-party analyst targets, dated to the 2026-09-15 screen.
Fair value and rating are our own model estimates; the Street's range reflects third-party analyst estimates. Analysis, not advice.
The Business, in Plain WordsCement Maker Trades Above Fair Value On Paper
Picture the steady flow of concrete into new US roads and homes. Titan America supplies those materials through its cement and aggregates network. The business earns an 11% profit margin and 19% ROE, yet revenue grows just 2% a year and our fair value sits 15% below the current price.
We pass. The forward multiple of 13.4 times looks modest, but this is a classic cyclical industry where peak earnings often flatter the numbers and leave investors holding the bag when construction slows. Analyst targets sit higher yet the consensus remains a hold, and our own valuation already prices in limited upside.
Ethical screens clear without issue. The real concern stays the same: low growth plus economic sensitivity means any apparent bargain can quickly turn into a value trap once volumes fall. Analysis, not advice.
| Forward P/E | 11.1xfairly priced for its growth rate |
| Trailing P/E | 14.6xreasonably valued |
| EPS, trailing | 0.96 |
| EPS, forward | 1.26 |
| Revenue growth | +9.6%steady growth |
| Profit margin | 10.4%thin but positive margins |
| Return on equity | 17.4%a solid return on shareholder capital |
| FCF yield | 4.12% |
| Dividend yield | 96.00% |
| Debt to equity | 0.53moderate, manageable leverage |
| Current ratio | 2.08comfortably covers its short-term bills |
| Short interest, float | 0.13% |
| 52-week range | 13.89 - 19.57 |
| Market cap | $2.6B |
| Employees | 2,554 |
The risks · The things to watch: its business and earnings are exposed to Belgium and to currency swings.
Plain-English interpretation of our own screen data. Analysis, not advice.
Where & How to TradeTTAM trades on the NYSE (the company is based in Belgium). As a listed security it is accessible through almost any international broker offering its home market. New to this, or investing from abroad? Our guide to accessing global markets covers brokers, currencies and the practical steps.
Every Entry, As Written
The framework has shifted from markup to distribution since the last review. Smart money appears to be selling into strength. Institutional holders may be rotating out. Price has moved down 3.6% since our last review. Ethical screening: PASS with passing ethical screen. The risk-adjusted return profile shows modest positive risk-adjusted returns. Our composite framework grades it C, carrying a low risk profile. Technically it is momentum reading neutral. Over the past year the shares are up 13%. Our forward projection puts the odds of a 10% gain over the next month near 23%. The street (7 analysts) rates it hold, with a mean price target of $18.
The framework reads markup. Price is trending higher with momentum. The crowd has caught on and buyers are in control. Price has moved down 0.0% since our last review. Ethical screening: PASS with passing ethical screen. The risk-adjusted return profile shows modest positive risk-adjusted returns. Our composite framework grades it C, carrying a low risk profile. Technically it is momentum reading neutral. Over the past year the shares are up 13%. Our forward projection puts the odds of a 10% gain over the next month near 23%. The street (7 analysts) rates it hold, with a mean price target of $18.
The framework reads markup. Price is trending higher with momentum. The crowd has caught on and buyers are in control. Price has moved down 0.0% since our last review. Ethical screening: PASS with passing ethical screen (70). The risk-adjusted return profile shows modest positive risk-adjusted returns.
The framework reads markup. Price is trending higher with momentum. The crowd has caught on and buyers are in control. Ethical screening: PASS with passing ethical screen (70). The risk-adjusted return profile shows modest positive risk-adjusted returns.
Each entry above was written on its date, before the outcome. A journal you can prune is not a journal.
Screened names in the same industry · explore each on its own page.
| Period | Price then | Price return | Divs per share | $1,000 became | Total return |
|---|---|---|---|---|---|
| 1 month | $16.67 | -5.9% | · | $941 | -5.9% |
| 2 months | $16.07 | -2.4% | $0.04 | $978 | -2.2% |
| 3 months | $15.76 | -0.5% | $0.04 | $997 | -0.3% |
| 6 months | $16.84 | -6.9% | $0.08 | $936 | -6.4% |
| 1 year | $13.82 | +13.5% | $0.12 | $1,144 | +14.4% |
Historical returns from market close data. Past performance does not guarantee future results.
This entry now belongs to the ledger. Whatever TTAM does next, these words stay.
Thirteen thousand names carry this page. One desk keeps them honest.
Membership opens the full screen archive, the composites built from it, and the daily coverage that prices what the screen approves.
Join the deskScreening is research, not a fatwa and not financial advice. Figures are drawn from public accounts at the screen date shown. Always manage your risk.